Cite
MLA Citation
Matthew S. Block et al.. “A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1.” Melanoma research, vol. 29, no. 4, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100108909396.0x000039